The co-occurrence of social anxiety symptoms and schizophrenia is a significant clinical problem. So far, social anxiety symptoms have been treated as an integral symptom of schizophrenia, receiving little attention as a target of direct therapeutic interventions. However, some evidence indicates that a high level of social anxiety in this group of patients may be a barrier to the recovery process. This feasibility study evaluated the use of a standard protocol for cognitive-behavioural therapy in the treatment of social phobia, in which social exposure was implemented with the usage of virtual reality (CBT + VRET). The study was conducted in a group of inpatients in a clinical psychiatric unit. Twenty inpatients diagnosed with schizophrenia and comorbid social anxiety symptoms were examined. Eleven patients were assigned to 10 weekly individual CBT+VRET interventions and nine to the control condition. Baseline and post-treatment assessments of social anxiety, psychotic symptoms, stigma, self-esteem, and depressive symptoms were measured before and after intervention. There was a decrease in social anxiety in the CBT+VRET group, while no such decrease was noted in the control group. This study provides preliminary evidence that CBT+VRET is acceptable, safe, and initial data that bears on the question of effectiveness for treating social anxiety disorder in people with schizophrenia. Future research should investigate the efficacy of CBT+VRET for the treatment of social anxiety symptoms and co-morbid schizophrenia in a larger randomised controlled trial.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11628405 | PMC |
http://dx.doi.org/10.3389/fpsyt.2024.1379541 | DOI Listing |
Arch Clin Neuropsychol
December 2024
Department of Psychology, University of Saskatchewan, 9 Campus Drive, Saskatoon, SK, S7N 5A5, Canada.
Objective: Technology can be combined with psychological interventions to support older adults with memory concerns. Using a bi-phasic design, cognitive rehabilitation (CR) was integrated with off-the-shelf technology and delivered to two people with cognitive impairment, and one care partner.
Method: Pre- and post-intervention assessments were completed for all participants.
BMC Psychol
December 2024
Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Background: There is a lack of self-report measures specifically designed for Adjustment disorder. One of the most widely used instruments is the Adjustment Disorder New Module (ADNM), which has already been validated in different countries. The aim of this study was to validate the Spanish version of the ADNM-20 with a non-clinical sample, including a comparison with a high-risk sample.
View Article and Find Full Text PDFPilot Feasibility Stud
December 2024
Lady Davis Institute for Medical Research, Montreal, QC, Canada.
Background: This pilot study aimed to provide supportive evidence for the feasibility of conducting a full-scale intervention trial with patients newly diagnosed with head and neck cancer (HNC). This included assessing the acceptability and potential usefulness of the PTSD Coach mobile app as an early self-management intervention that gives information about anxiety symptoms, offers self-assessment of symptoms with feedback, tools to self-manage anxiety, and connects to support.
Methods: A three-arm randomized controlled trial was conducted.
Mol Autism
December 2024
Department of Neurosciences, Center for Developmental Psychiatry, KU Leuven, Leuven, Belgium.
Background: Difficulties with (non-verbal) social communication, including facial expression processing, constitute a hallmark of autism. Intranasal administration of oxytocin has been considered a potential therapeutic option for improving social difficulties in autism, either by enhancing the salience of social cues or by reducing the social stress and anxiety experienced in social encounters.
Methods: We recorded fMRI brain activity while presenting neutral, fearful and scrambled faces, to compare the neural face processing signature of autistic children (n = 58) with that of matched non-autistic controls (n = 38).
BMC Womens Health
December 2024
Nursing Department, The Third Xiangya Hospital, Central South University, Changsha, China.
Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. Body image distress (BID) refers to psychological distress caused by deviations in the individual's self-aesthetic ability. The objectives of this study are to investigate the prevalence of psychological distress; and to assess the role of anxiety in the relationship between body image distress and quality of life (QoL) among women with polycystic ovary syndrome using a path analysis approach.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!